The STOP-CDI intervention presented by Matthew J.Ziegler, MD MSCE revealed using prophylactic enteral vancomycin, significantly reduced hospital-onset C difficile infections among immunocompromised patients.
Matthew J Ziegler, MD MSCE
Advertisement
Assistant Professor of Medicine at the University of Pennsylvania.
Articles by Matthew J Ziegler, MD MSCE
Advertisement
Latest Updated Articles
Targeted Prophylaxis Reduces Hospital-Onset C difficile Infections in High-Risk PatientsPublished: October 22nd 2024 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
One Third of Chronic Hepatitis B Patients Are Lost to Follow-Up
2
Higher Acceptability of 1 Injectable in First Head-to-Head Comparison of Long-Acting PrEP
3
Is 4 Weeks of Glecaprevir/Pibrentasvir Sufficient to Treat Early Hepatitis C Infection?
4
Antibiotic Shows Promise in Treating Gram-Positive Pneumonia, Including in High-Risk Patients
5
